Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Cooper, BS; Stone, SP; Kibbler, CC; Cookson, BD; Roberts, JA; Medley, GF; Duckworth, G; Lai, R; Ebrahim, S (2004)
Languages: English
Types: Article
Objective To evaluate the evidence for the effectiveness of isolation measures in reducing the incidence of methicillin resistant Staphylococcus aureus (MRSA) colonisation and infection in hospital inpatients. Design Systematic review of published articles. Data sources Medline, Embase, CINAHL, Cochrane Library, System for Information on Grey Literature in Europe (SIGLE), and citation lists (1966-2000). Review methods Articles reporting MRSA related outcomes and describing an isolation policy were selected. No quality restrictions were imposed on studies using isolation wards or nurse. cohorting. Other studies were included if they were prospective or employed planned comparisons of retrospective data. Results 46 studies were accepted; 18 used isolation wards, nine used nurse cohorting, and 19 used other isolation policies. Most were interrupted time series, with few planned formal prospective studies. All but one reported multiple interventions. Consideration of potential confounders, measures to prevent bias, and appropriate statistical analysis were mostly lacking. No conclusions could be drawn in a third of studies. Most others provided evidence consistent with a reduction of MRSA acquisition. Six long interrupted time series provided the strongest evidence. Four of these provided evidence that intensive control measures including patient isolation were effective in controlling MRSA. In two others, isolation wards failed to prevent endemic MRSA. Conclusion Major methodological weaknesses and inadequate reporting in published research mean that many plausible alternative explanations for reductions in MRSA acquisition associated with interventions cannot be excluded. No well designed studies exist that allow the role of isolation measures alone to be assessed. None the less, there is evidence that concerted efforts that include isolation can reduce MRSA even in endemic settings. Current isolation measures recommended in national guidelines should continue to be applied until further research establishes otherwise.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1 Public Health Laboratory Service. The first year of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS trusts in England: April 2001-March 2002. Commun Dis Rep CDR Wkly [serial online] 2002;12: www.hpa.org.uk/cdr/PDFfiles/2002/cdr2502.pdf (accessed 22 Jul 2004).
    • 2 Hiramatsu K, Hanaki H, Ino T. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-6.
    • 3 Turnidge JD, Bell JM Methicillin-resistant Staphylococcus aureus evolution in Australia over 35 years. Microb Drug Resist 2000;6:223-9.
    • 4 Centers for Disease Control and Prevention. National nosocomial infection surveillance systems report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2002;30:458-75.
    • 5 Garner JS. Hospital infection control practices advisory commitee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53-80.
    • 6 Wierkgroup Infectie Preventie. Management policy for methicillin-resistant Staphylococcus aureus. Guideline No. 35A. Leiden: WIP, 1994.
    • 7 Ministry of Health. Guidelines for the control of methicillin-resistant Staphylococcus aureus in New Zealand. Wellington: MoH, 2002. www.moh.govt.nz/moh.nsf/ 49ba80c00757b8804c256673001d47d0/e5231b74a5dc8b22cc256c220017b248/ $FILE/mrsa.pdf (accessed 12 Jul 2004).
    • 8 British Society for Antimicrobial Chemotherapy, Hospital Infection Society and the Infection Control Nurses Association. Revised guidelines for the control of methicillinresistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998;39:253-90.
    • 9 Rahman M, Sanderson PJ, Bentley AH, Barrett SP, Karim QN, Teare EL, et al. Control of MRSA. J Hosp Infect 2000;44:151-3.
    • 10 Boyce JM. Nosocomial staphylococcal infections. Ann Intern Med 1981;95:241-2.
    • 11 Stone SP. Managing methicillin-resistant Staphylococcus aureus in hospital: the balance of risk. Age Ageing 1997;26:165-8.
    • 12 Cook TD, Campbell DT. Quasi-experimentation: design and analysis issues for field settings. Chicago: Rand McNally College Publications, 1979.
    • 13 Grimes DA, Schulz KF. Cohort studies: marching towards outcomes. Lancet 2002; 359:341-5.
    • 14 Cochrane Effective Practice and Organisation of Care (EPOC) Review Group. Cochrane Library Database. Oxford: 2001. Issue 1. Update software .
    • 15 Morton V, Torgerson DJ. Effect of regression to the mean on decision making in health care. BMJ 2003 May 17;326:1083-4.
    • 16 Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth GJ, Lai R, Ebrahim S. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess 2003;7:1-194.
    • 17 Alvarez S, Shell C, Gage K, Guarderas J, Kasprzyk D, Besing J, et al. An outbreak of methicillin-resistant Staphylococcus aureus eradicated from a large teaching hospital. Am J Infect Control 1985;13:115-21.
    • 18 Arnow P, Allyn PA, Nichols EM, Hill DL, Pezzlo M, Bartlett RH. Control of methicillinresistant Staphylococcus aureus in a burn unit: role of nurse staffing. J Trauma 1982;22:954-9.
    • 19 Back NA, Linnemann CC, Jr., Staneck JL, Kotagal UR. Control of methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit: use of intensive microbiologic surveillance and mupirocin. Infect Control Hospital Epidemiol 1996;17:227-31.
    • 20 Barakate MS, Harris JP, West RH, Vickery AM, Sharp CA, Macleod C, et al. A prospective survey of current methicillin-resistant Staphylococcus aureus control measures. Austr N Z J Surg 1999;69:712-6.
    • 21 Barakate MS, Yang YX, Foo SH, Vickery AM, Sharp CA, Fowler LD, et al. An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital. J Hosp Infect 2000;44:19-26.
    • 22 Blumberg LH, Klugman KP. Control of methicillin-resistant Staphylococcus aureus bacteraemia in high-risk areas. Eur J Clin Microbiol Infect Dis 1994;13:82-5.
    • 23 Brady LM, Thomson M, Palmer MA, Harkness JL. Successful control of endemic MRSA in a cardiothoracic surgical unit. Med J Austr 1990;152:240-5.
    • 24 Campbell JR, Zaccaria E, Mason EO Jr, Baker CJ. Epidemiological analysis defining concurrent outbreaks of Serratia marcescens and methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit. Infect Control Hosp Epidemiol 1998;19:924-928.
    • 25 Coello R, Jimenez J, Garcia M, Arroyo P, Minguez D, Fernandez C, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994;13:74-81.
    • 26 Cosseron-Zerbib M, Roque Afonso AM, Naas T, Durand P, Meyer L, Costa et al. A control programme for MRSA (methicillin-resistant Staphylococcus aureus) containment in a paediatric intensive care unit: evaluation and impact on infections caused by other micro-organisms. J Hosp Infect 1998;40:225-35.
    • 27 Cox RA, Conquest C, Mallaghan C, Marples RR. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 1995;29:87-106.
    • 28 Duckworth GJ, Lothian JL, Williams JD. Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital. J Hosp Infect 1988;11:1-15.
    • 29 El Hagrasy M. An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) in a hospital in the UAE: Problems and solutions. Emirates Med J 1997;15:17-21.
    • 30 Esveld MI, de Boer AS, Notenboom AJ, van Pelt W, van Leeuwen WJ. [Secondary infection with methicillin resistant Staphylococcus aureus in Dutch hospitals (July 1994-June 1996]. Nederlands Tijdschrift voor Geneeskunde 1999;143:205-8.
    • 31 Faoagali JL, Thong ML, Grant D. Ten years' experience with methicillin-resistant Staphylococcus aureus in a large Australian hospital. J Hosp Infect 1992;20:113-9.
    • 32 Farrington M, Redpath C, Trundle C, Coomber S, Brown NM. Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus (MRSA) at a teaching hospital. QJM 1998:91:539-48.
    • 33 Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543-50.
    • 34 Girou E, Azar J, Wolkenstein P, Cizeau F, Brun-Buisson C, Roujeau JC. Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward. Infect Control Hosp Epidemiol 2000;21:583-7.
    • 35 Harbarth S, Martin Y, Rohner P, Henry N, Auckenthaler R, Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000;46:43-9.
    • 36 Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000;356:1307-12.
    • 37 Hartstein AI, LeMonte AM, Iwamoto PK. DNA typing and control of methicillinresistant Staphylococcus aureus at two affiliated hospitals. Infect Control Hosp Epidemiol 1997;18:42-8.
    • 38 Jernigan JA, Titus MG, Groschel DH, Getchell-White S, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496-504.
    • 39 Jones MR, Martin DR. Outbreak of methicillin-resistant Staphylococcus aureus infection in a New Zealand hospital. N Z Med J 1987;100:369-73.
    • 40 Kac G, Buu-Hoi A, Herisson E, Biancardini P, Debure C. Methicillin-resistant Staphylococcus aureus. Nosocomial acquisition and carrier state in a wound care center. Arch Dermatol 2000;136:735-9.
    • 41 Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28:1062-6.
    • 42 Law MR, Gill ON, Turner A. Methicillin-resistant Staphylococcus aureus: associated morbidity and effectiveness of control measures. Epidemiol Infect 1988;101:301-9.
    • 43 Linnemann CC, Jr., Mason M, Moore P, Korfhagen TR, Staneck JL. Methicillin-resistant Staphylococcus aureus: experience in a general hospital over four years. Am J Epidemiol 1982;115:941-50.
    • 44 Lugeon C, Blanc DS, Wenger A, Francioli P. Molecular epidemiology of methicillin-resistant Staphylococcus aureus at a low-incidence hospital over a 4-year period. Infect Control Hospital Epidemiol 1995;16:260-7.
    • 45 Mayall B, Martin R, Keenan AM, Irving L, Leeson P, Lamb K. Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillinresistant Staphylococcus aureus in an open ward. J Hosp Infect 1996;32:257-26.
    • 46 Murray-Leisure KA, Geib S, Graceley D, Rubin-Slutsky AB, Saxena N, Muller HA, et al. Control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1990;11:343-50.
    • 47 Onesko KM, Wienke EC. The analysis of the impact of a mild, low-iodine, lotion soap on the reduction of nosocomial methicillin-resistant Staphylococcus aureus: a new opportunity for surveillance by objectives. Infect Control 1987;8:284-8.
    • 48 Oto MA, Pinto CME, Martinez CV, Fabio BC, Soza MA, Jerez RA, et al. Control of methicillin resistant Staphylococcus aureus at a neonatal ward. Rev Chil Pediatr 1992;63:134-8.
    • 49 Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999;20:473-7.
    • 50 Pearman JW, Christiansen KJ, Annear DI, Goodwin CS, Metcalf C, Donovan FP, et al. Control of methicillin-resistant Staphylococcus aureus (MRSA) in an Australian metropolitan teaching hospital complex. Med J Austr 1985;142:103-8.
    • 51 Pfaller MA, Wakefield DS, Hollis R, Frederickson M, Evans E, Massanari RM. The clinical microbiology laboratory as an aid in infection control. The application of molecular techniques in epidemiologic studies of methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 1991;14:209-17.
    • 52 Ribner BS, Landry MN, Gholson GL. Strict versus modified isolation for prevention of nosocomial transmission of methicillin-resistant Staphylococcus aureus. Infect Control 1986;7:317-20.
    • 53 Schlunzen L, Lund B, Schouenborg P, Skov RL. [Outbreak of methicillin resistant Staphylococcus aureus in a central hospital]. Ugeskrift for Laeger 1997;159:431-5.
    • 54 Selkon JB, Stokes ER, Ingham HR. The role of an isolation unit in the control of hospital infection with methicillin-resistant staphylococci. J Hosp Infect 1980;1:41-6.
    • 55 Shanson DC, Kensit JC, Duke R. Outbreak of hospital infection with a strain of Staphylococcus aureus resistant to gentamicin and methicillin. Lancet 1976;2:1347-8.
    • 56 Shanson DC, Johnstone D, Midgley J. Control of a hospital outbreak of methicillin-resistant Staphylococcus aureus infections: value of an isolation unit. J Hosp Infect 1985;6:285-292.
    • 57 Souweine B, Traore O, Aublet-Cuvelier B, Bret L, Sirot J, Laveran H, et al. Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect 2000;45:107-16.
    • 58 Stone SP, Beric V, Quick A, Balestrini AA, Kibbler CC. The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphylococcus aureus colonization in acute elderly medical patients. Age Ageing 1998 ;27:561-8.
    • 59 Talon D, Rouget C, Cailleaux V, Bailly P, Thouverez M, Barale F, et al. Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive care unit: Efficacy of mupirocin ointment. J Hosp Infect 1995;30:39-49.
    • 60 Tambic A, Power EG, Tambic T, Snur I, French GL. Epidemiological analysis of methicillin-resistant Staphylococcus aureus in a Zagreb Trauma Hospital using a randomly amplified polymorphic DNA-typing method. Eur J Clin Microbiol Infect Dis 1999;18:335-40.
    • 61 Ward TT, Winn RE, Hartstein AI, Sewell DL. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: role of antimicrobial therapy in infection control. Infect Control 1981;2:453-9.
    • 62 Yano M, Doki Y, Inoue M, Tsujinaka T, Shiozaki H, Monden M. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg Today 2000;30:16-21.
    • 63 Yoshida J, Kuroki S, Akazawa K, Chijiiwa K, Takemori K, Torisu M, et al. The order of ward rounds influences nosocomial infection. A 2-year study in gastroenterologic surgery patients. J Gastroenterol 1995;30:718-24.
    • 64 Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-28.
    • 65 Spicer WJ. Three strategies in the control of staphylococci including methicillinresistant Staphylococcus aureus. J Hosp Infect 1984;5(suppl A):45-9.
    • 66 Bell SM. Recommendations for control of the spread of methicillin resistant Staphylococcus aureus infection. Med J Austr 1982;2:472-4.
    • 67 Farr BM, Salgado CD, Karchmer TB, Sheretz RJ. Can antibiotic resistant nosocomail infections be controlled? Lancet Infect Dis 2001;1:38-45.
    • 68 Crowcroft NS, Catchpole M. Mortality from methicillin resistant Staphylococcus aureus in England and Wales: analysis of death certificates. BMJ 2002;325:1390-1.
    • 69 Centers for Disease Control and Prevention. Staphylococcus areus resistant to vancomycin-United States, 2002. Morb Mortal Wkly Rep MMWR 2002;51:565-7.
    • 70 Perry CN, Jarvis B Linezolid: a review of its use in the management of serious gram positive infections. Drugs 2001;61:525-51.
    • 1 Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004;329:533-8.
    • 2 Biant LC, Teare EL, Williams WW, Tuite JD. Eradication of methicillin-resistant Staphylococcus aureus by “ring fencing” of elective orthopaedic beds. BMJ 2004;329:149-51.
    • 3 Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guidelines for preventing nosocomial transmission of multi-drug resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-86.
    • 28 New End Square, London NW3 1LS Geoff Watts science editor, BMJ
  • No related research data.
  • No similar publications.

Share - Bookmark

Download from

Cite this article